AIG develops Hemospray to Halt Gastrointestinal Bleeding

Hyderabad: The city-based Asian Institute of Gastroenterology (AIG) has set yet another milestone by developing the Hemospray technology for stopping upper GI bleeding.  Thus they have become the first in India, to accomplish this unique and innovative treatment.

AIG Hospitals indeed is one of the World’s largest Gastrointestinal (GI) Centre of Excellence. This cutting-edge endoscopic spray stops internal bleeding in less than 10 minutes, significantly improving the risk of death. 

Speaking on the importance of this technology, the Group’s Chairman and Chief of Gastroenterology, Dr. D Nageshwar Reddy, said “We are entering a new era of endoscopic innovation, dedicated to providing optimal outcomes for our patients. In this regard, the transformative potential of Hemospray – a mineral blend powder meticulously crafted for hemostasis (the process of stopping the bleeding). With its reassuring attributes of no human or animal proteins, allergen-free formulation, and metabolic inertness, this spray represents a game-changer in ensuring both safety and efficacy in gastrointestinal interventions.”

The first use case of Hemospray in India was performed by Dr. D Nageshwar Reddy and Dr. Mohan Ramchandani on a 49-year-old female liver cirrhosis patient reporting to the emergency with a complaint of black, tarry stools, an indication of active GI bleeding. Dr. Reddy successfully demonstrated that Hemospray was able to control the bleeding.

“The most important use-case of Hemosprawould be in emergencies, where even a resident doctor can use the device and stop the bleeding immediately and therefore saving a patient’s life,” Dr. Mohan Ramchandani, Director, Therapeutic Endoscopy, AIG Hospitals said.

Present on the occasion was Prof. James Lau from the Prince of Wales Hospital, Hong Kong who is a pioneer of endovascular surgery for vascular diseases. Dr. Lau said, “Hemospray has excellent application, especially for active bleeding, and provides good primary control, enabling endoscopists to plan better to rectify the cause of the bleeding.”

Dr. Reddy concluded that “GI bleeding poses a significant threat to life due to the potential for severe blood loss. When bleeding occurs in the gastrointestinal tract, such as the esophagus, stomach, or duodenum, it can lead to a rapid and substantial loss of blood. This can result in a condition known as hemorrhagic shock, where the body is unable to maintain adequate blood flow to vital organs. Without prompt intervention to stop the bleeding and restore blood volume, non-variceal bleeding can be life-threatening, contributing to mortality. We are happy to have an innovative product like Hemospray which will greatly help our patients coming with an active GI bleed.”